Trioxsalen

CHEMBL1475 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
228.2 g/mol
LogP
3.0
Phase
4

Trioxsalen is a psoralen compound (furocoumarin) that intercalates into DNA and, upon activation by ultraviolet A (UVA) light, forms covalent crosslinks between DNA strands, inhibiting cellular proliferation. It is used in photochemotherapy (PUVA) for skin conditions such as vitiligo and mycosis fungoides, and has been investigated as a photosensitizing agent in certain cancers including bladder and breast cancer. Its photodynamic mechanism requires careful UV exposure control to minimize side effects.

आणविक भार

228.2400 g/mol

LogP

3.00

TPSA

39.40 Ų

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

क्रिया का तंत्र

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

तंत्र

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1

InChI

InChI=1S/C14H12O3/c1-7-4-12(15)17-14-9(3)13-10(6-11(7)14)5-8(2)16-13/h4-6H,1-3H3

Molecular Formula

C14H12O3

HBD / HBA

- / 3

घूर्णनीय बंधन

0

भारी परमाणु

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

Trioxsalen is a psoralen compound (furocoumarin) that intercalates into DNA and, upon activation by ultraviolet A (UVA) light, forms covalent crosslinks between DNA strands, inhibiting cellular proliferation. It is used in photochemotherapy (PUVA) for skin conditions such as vitiligo and mycosis fungoides, and has been investigated as a photosensitizing agent in certain cancers including bladder and breast cancer. Its photodynamic mechanism requires careful UV exposure control to minimize side effects.

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

Yes, Trioxsalen is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1475. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5585. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.